Analysts have recently evaluated Charles River and provided 12-month price targets. The average target is $214.5, accompanied by a high estimate of $250.00 and a low estimate of $185.00. A 2.72% drop ...

The outlook for Wilmington, Massachusetts-based contract research organization (CRO) Charles River Laboratories International ...

Charles River Laboratories (NYSE:CRL) lost ~12% in the premarket on Tuesday after the contract research organization said its 2025 revenue on an organic basis is expected to decline at a similar ...

In addition to being a partner at Charles River Ventures, he co-founded nonprofit MaiTai Global, a professional networking group that merges work, play and philanthropy. MaiTai also heads up the ...

OptimX Markets has moved to expand its ability to offer institutional clients bilateral liquidity with a new integration with State Street’s order and execution platform, Charles River. As part of the ...

Wilmington, Massachusetts-based Charles River Laboratories International, Inc. (CRL) provides drug discovery, non-clinical development, and safety testing services. Valued at $8.6 billion by ...

Bank of America Securities analyst Juan Avendano reiterated a Hold rating on Charles River Labs (CRL – Research Report) today and set a price ...

6 analysts have shared their evaluations of Charles River (NYSE:CRL) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below provides a snapshot of ...